Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.93 |
| ▸ | FDPS | P14324 | 15/20 | 0.47 |
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etidronic Acid SCHEMBL1527591 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL94632 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL205727 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL17961664 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL7764099 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL4595371 | 1.00 | LMNA (0.93) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10957057 | 0.97 | LMNA (0.87) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL6850113 | 0.97 | LMNA (0.87) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL10705565 | 0.97 | LMNA (0.87) | LMNAFDPSPGK1PGK2CA2 | |
| Etidronic Acid SCHEMBL18607 | 0.96 | LMNA (1.00) | LMNAFDPSPGK1PGK2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2387 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260112640-A1 | NEGATIVE-ELECTRODE MATERIAL FOR SECONDARY BATTERY, AND SECONDARY BATTERY | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-04-23 | — | — | US | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| EP-4597619-A1 | NEGATIVE-ELECTRODE MATERIAL FOR SECONDARY BATTERY, AND SECONDARY BATTERY | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2025-08-06 | — | — | EP | claimed |
| EP-4597620-A1 | NEGATIVE-ELECTRODE MATERIAL FOR SECONDARY BATTERY, AND SECONDARY BATTERY | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2025-08-06 | — | — | EP | claimed |
| CN-119856296-A | Negative electrode material for secondary battery and secondary battery | 松下知识产权经营株式会社 | 2025-04-18 | — | — | CN | claimed |
| CN-119856295-A | Negative electrode material for secondary battery and secondary battery | 松下知识产权经营株式会社 | 2025-04-18 | — | — | CN | claimed |
| CN-119462024-A | Synchronous grouting material based on argillaceous powder sand shield muck and preparation method thereof | 中国建筑第五工程局有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| CN-118649295-A | Degradable drug-loaded fiber membrane for vertebral body saccule and preparation process thereof | 山东百多安医疗器械股份有限公司 | 2024-09-17 | — | — | CN | claimed |
| EP-3691450-B1 | QUATERNARY AMMONIUM ETIDRONATES | INNOVATIVE WATER CARE LLC (US) | 2024-08-21 | — | — | EP | claimed |
| US-5958907-A | Pharmaceutical compositions and uses of inorganic pyrophosphates | THE UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1999-09-28 | — | — | US | claimed |
| EP-0935523-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GENERAL MILLS, INC. (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1999029345-A1 | INHIBITION OF TUMOR GROWTH BY MACROPHAGE INTERVENTION | LA JOLLA INSTITUTE FOR EXPERIMENTAL MEDICINE (US) | 1999-06-17 | — | — | WO | claimed |
| US-5898038-A | ADMINISTERING NITROGLYCERINE AND A BISPHOSPHONATE SELECTED FROM DISODIUM ETIDRONATE, PAMIDRONATE, CLODRONATE, RESIDRONATE OR ALENDRONATE TO THE PATIENT SUFFERING FROM PRIMARY AND SECONDARY OSTEOPROSIS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-04-27 | — | — | US | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| WO-1998018610-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | LENGERICH BERNHARD H VAN (US) | 1998-05-07 | — | — | WO | claimed |
| WO-1997034609-A1 | TREATMENT OF OSTEOPOROSIS AND METABOLIC BONE DISORDERS WITH NITRIC OXIDE SUBSTRATE AND/OR DONORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-09-25 | — | — | WO | claimed |
| US-4830779-A | CONTAINING METAL POWDER, DIPHOSPHONATE, HYDROXYL COMPOUND | LION CORPORATION (JP) | 1989-05-16 | — | — | US | claimed |
| US-4747966-A | DIPHOSPHONIC ACID, SEQUESTERING AGENT | LION CORPORATION (JP) | 1988-05-31 | — | — | US | claimed |
| US-4634544-A | DISCOLORATION INHIBITION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1987-01-06 | — | — | US | claimed |